API Holdings will use the new funds to repay previous NCD debt. Earlier, it had issued NCDs worth ₹1,820 Cr, with ₹1,545.4 Cr still outstanding, according to an exchange filing.
Rahul Guha, currently CEO of Thyrocare, will become the new CEO of Pharmeasy. API Holdings bought 66.1% of Thyrocare for ₹4,546 crore in June 2021. Thyrocare is a publicly listed company, while Pharmeasy is yet to go public.
Bengaluru-based online pharmacy company PharmEasy is going through a big change as three co-founders—Dharmil Sheth, Dhaval Shah and Hardik Dedhia—have stepped back from the company.
PharmEasy, Netmeds, cult.fit, Innovaccer, Practo, HealthifyMe, Tata Health, NIRAMAI, Docplexus, and ekincare are the Best HealthTech Startups in India in 2024.
/viestories/media/media_files/2025/09/16/healthtech-unicorn-pharmeasy-to-raise-rs-1700-cr-debt-2025-09-16-16-43-20.png)
/viestories/media/media_files/2025/08/07/pharmeasy-founder-siddharth-shah-steps-down-as-ceo-2025-08-07-08-32-39.png)
/viestories/media/media_files/2025/01/24/bKvCAUBcZRLYZFyvwAYL.png)
/viestories/media/post_attachments/wp-content/uploads/2023/03/health-tech-startups.jpg)
/viestories/media/post_attachments/wp-content/uploads/2023/10/Which-is-the-most-rich-startup-in-India-01-1-scaled.webp)
/viestories/media/post_attachments/wp-content/uploads/2023/09/Best-Tech-Startups-in-India-scaled.webp)